Nigerian epidemiologist and WHO assistant director-general
The Bundibugyo-strain Ebola outbreak in the DR Congo has intensified, with cases rising and deaths increasing. Health workers are striking over unpaid salaries, while international partners warn the official figures may undercount the true toll. Trials for treatments have begun, and vaccination efforts remain limited by the absence of a vaccine for this strain.
A UK-Oxford vaccine candidate has begun Phase I testing in healthy volunteers to assess safety and immune response. The work leverages the same technology as the Oxford–AstraZeneca Covid jab. Trials are planned in Africa with regional partners as the outbreak continues in the Democratic Republic of Congo.